Human Mesenchymal Stem Cells: The Present Alternative for High-Incidence Diseases, Even SARS-Cov-2

Figure 5

Worldwide map of registered clinical trials employing mesenchymal stem cells. The color indicates the number of studies within a region; exact study numbers are enclosed into labels. The number of studies by region: Africa 15, Central America 10, East Asia 354, Japan 9, Europe 206, Middle East 85, North America 230, Canada 15, Mexico 3, United States 220, North Asia 26, Pacifica 8, South America 31, South Asia 29, and Southeast Asia 29. Extracted and modified from http://www.clinicaltrials.gov.